8th Oct 2014 07:44
8 October 2014
Allergy Therapeutics plc
("Allergy Therapeutics" or the "Company")
Directorate Change
Allergy Therapeutics plc (AIM: AGY), the fully integrated speciality pharmaceutical company specialising in allergy vaccines, announces that Alejandro Esteban Weinstein Manieu has stepped down from the Board with immediate effect.
Peter Jensen, Chairman of the Board, said: "Alejandro has made an enormous contribution to the development of Allergy Therapeutics since his involvement in 2009 and I would like to take this opportunity to thank him for his valuable guidance and support."
For further information
Allergy Therapeutics | +44 (0) 1903 845 820 |
Manuel Llobet, Chief Executive Officer Ian Postlethwaite, Finance Director | |
Peel Hunt LLP | +44 (0) 20 7418 8900 |
James Steel Clare Terlouw | |
FTI Consulting | +44 (0) 20 3727 1000 |
Simon Conway Victoria Foster Mitchell |
Notes to editors
About Allergy Therapeutics
Allergy Therapeutics is a specialty pharmaceutical company focused on allergy vaccination. It has a growing business achieving revenue in the last financial year of £42 million mainly in Europe through its own sales and marketing infrastructure and further afield through distributors. The Company is expanding its infrastructure into the Emerging Markets
Related Shares:
Allergy Thera.